Difference between revisions of "Team:Hong Kong HKU/Design"

(Update)
 
Line 75: Line 75:
 
         The oligo sequences are shown below:<br>
 
         The oligo sequences are shown below:<br>
 
         </font></p>
 
         </font></p>
         <img class="img-responsive center-block" width="600px" height="auto" src="https://static.igem.org/mediawiki/2016/9/91/T--Hong_Kong_HKU--TetraDesign1.png" alt="">
+
         <img class="img-responsive center-block" width="600px" height="auto" src="https://static.igem.org/mediawiki/2016/9/91/T--Hong_Kong_HKU--TetraDesign1.png" alt=""><br>
 
         <table class="table">
 
         <table class="table">
 
         <thead>
 
         <thead>
Line 112: Line 112:
 
             </tbody>
 
             </tbody>
 
         </table>
 
         </table>
 +
        <br>
 +
        <img class="img-responsive center-block" width="600px" height="auto" src="https://static.igem.org/mediawiki/2016/8/83/T--Hong_Kong_HKU--TetraDesign2.png" alt="">
 
         <br>
 
         <br>
 
         <p class="text-justify" align="left"><font size="3">
 
         <p class="text-justify" align="left"><font size="3">

Latest revision as of 19:51, 19 October 2016

Project

Design

Our design is a tetrahedral nanostructure for diagnostic purposes. It consists of five oligonucleotides (oligos, O1 to O5) with lengths ranging from 30 to 97 nucleotides. The oligos are assembled by heating at 95ºC for 5 minutes and then cooled to 25ºC. The details of the DNA nanostructure assembly can be found in here. The oligo sequences are shown below:


Tetra forming Oligo Sequence Size (nucleotide)
Oligo 1 CTACTAGCTGCACGACGTAGTGGGTTGGGTCTAACTCCACTGGGTAGGGTCGT
CGAGCTCACGTGCGTCACGCGCGATAGTCGAGTGCTGCTGAGTA
97
Oligo 2 CTACGAGTGATGACGAGACATGTGACAGTGCACACTATGTGCGCTCATCGCAC
GATAGCAGACGACG
67
Oligo 3 TGACGCACGTGAGCACTGCTATCGTGCGATGAGCGCACATAGACTGACACACG
CATGACGCTATCGCAGCACGACTATCGCGCG
84
Oligo 4 GTCTCGTCATCACACGTGCAGCTAGTAGTACTCAGCAGCACAGCTGCGATAGC
GTCATGCGTGTGTCAGAGTGCACTGTCACAT
84
Oligo 5 ATGGCACCCAGTGGAGTTAGACCCTGATTG 30


To test our design, we used a miRNA sequence found in patients who have high risks of acquiring Huntington disease. The miRNA is expected to displace O5 from the tetrahedral structure. With Oligo 5 displaced, steric hindrance within the tetrahedron would hence be reduced. Oligo 1 would then be able to fold into a G-quadruplex structure, which serves as a DNAzyme to catalyze the reaction between hemin, ABTS and hydrogen peroxide, which gives a green color. The sequence of the miRNA for Huntington disease used for testing is shown below:

Input Oligo Sequence Size (nucleotide)
Input CAATCAGGGTCTAACTCCACTGGGTGCCAT 30
RNA Input CAAUCAGGGUCUAACUCCACUGGGUGCCAU 30

For future development as a diagnostic tool with broader applications, part of the DNA sequence can be altered for the detection of other miRNAs for various diseases.


Copyright © 2016 HKU iGEM. All rights reserved.